Market Access Strategies for the Global Healthcare Environment mktxs linkedin 1-908-864-4090
serv_1

Evidence Generation

Our goal is to evaluate disease epidemiology and build and demonstrate product value proposition enabling our clients to defend their product positioning and gain optimal access. We generate disease-specific messages and product differentiation messages, highlighting unmet needs, as well as clinical, economic and humanistic attributes of the product.

What we do

 

Restrospective Chart Review Studies

Chart review logo
  • We leverage online physician/HCP panels (>1.5 million HCPs from 20+ countries), with established contracts and negotiated remuneration rates
  • Our immediate access enables electronic data collection within 6-12 weeks
  • From patient medical charts, we collect longitudinal data encompassing demographics, disease diagnoses, clinical characteristics, treatments, outcomes (incl. physician global assessments), AEs, HRUs, reasons for treatment start/stop, etc

                                           

Cross-sectional surveys

Chart review logo
  • We leverage online patient/consumer panels (>16 million) & HCP panels (>1.5 million) and hundreds of payers and key influencers from 20+ countries, with established remuneration rates
  • Our immediate access enables electronic data collection within 6-12 weeks
    • From patients/caregivers: Attitudes, treatments (incl. OTC use), PROs/HRQoL, out-of-pocket costs, WTP
    • From HCPs: Attitudes/behaviors, drivers/barriers, unmet needs, use of quality care metrics, treatment patterns
    • From payers and key influencers: Access landscape, restrictions, drivers, unmet need

Observational Cohort Studies/Registries

Chart review logo
  • We leverage clinical site from most major healthcare markets
  • We establish site-specific contracts, central/regional/local ethics approvals and protocol-driven data collection procedures (electronic or paper-based)
  • We recruit patients via physicians and establish prospective cohorts for cross-sectional and longitudinal study designs, combining medical chart reviews and patient surveys (linked at patient-level)

 

How Can MKTXS Help You?

 

Sample MKTXS Engagements to Optimize an Assets Lifecycle Revenue

  • PHASE 1
    • Disease Epidemiology
    • BOI Assessment
    • Treatment/Care Pattern and Unmet Need Assessment
  • PHASE 2
    • Disease Epidemiology
    • BOI Assessment
    • Treatment/Care Pattern and Unmet Need Assessment
  • PHASE 3
    • Treatment/Care Pattern and Unmet Need Assessment
    • Patient Perceptions, Burden (incl. HRQoL), Unmet Needs
    • HCP Perceptions and Unmet Needs
  • PHASE 4
    • Treatment/Care Pattern and Unmet Need Assessment
    • Patient Perceptions, Burden (incl. HRQoL), Unmet Needs
    • HCP Perceptions and Unmet Needs
PHASE 1 PHASE 2 PHASE 3 PHASE 4